# IGC Pharma, Inc.: Form 8-K, filed Apr 5, 2017

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2017-04-05
- Accepted by EDGAR: Apr 4, 2017, 19:35 ET
- Period: 2017-04-03
- Accession: 0001185185-17-000815
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518517000815/indiaglobalization8k040417.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518517000815/

## Items reported

- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518517000815/indiaglobalization8k040417.htm

Filed Apr 5, 2017.
Source: SEC EDGAR, the filing index for accession 0001185185-17-000815. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
